A Retrospective Review of the Use of Regional Citrate Anticoagulation in Continuous Venovenous Hemofiltration for Critically Ill Patients
Open Access
- 28 January 2013
- journal article
- review article
- Published by Hindawi Limited in Critical Care Research and Practice
- Vol. 2013, 1-7
Abstract
Background. The emergence of a commercially prepared citrate solution has revolutionized the use of RCA in the intensive care unit (ICU). The aim of this study was to evaluate the safety profile of a commercially prepared citrate solution.Method. Predilution continuous venovenous hemofiltration (CVVH) was performed using Prismocitrate 10/2 at 2500 mL/h and a blood flow rate of 150 mL/min. Calcium chloride solution was infused to maintain ionized calcium within 1.0–1.2 mmol/L. An 8.4% sodium bicarbonate solution was infused separately. Treatment was stopped when the predefined clinical target was reached or the filter clotted.Result. 58 sessions of citrate RCA were analyzed. The median circuit lifetime was 26.0 h (interquartile range IQR 21.2–44.3). The percentage of circuits lasting more than 12 h, 24 h, and 48 h was 94.6%, 58.9%, and 16.1%, respectively. There was no incidence of hypernatremia and median pH was 2.5, only four patients had evidence of citrate accumulation.Conclusion. The commercially prepared citrate solution could be used safely in critically ill patients who required CVVH with no major adverse events.Keywords
This publication has 23 references indexed in Scilit:
- Continuous venovenous hemodialysis with regional citrate anticoagulation in patients with liver failure: a prospective observational studyCritical Care, 2012
- Comparison of the efficacy and safety of two regional citrate anticoagulation protocols using acid citrate dextrose A or Prismocitrate 10/2, in patients with acute renal failure undergoing continuous venovenous haemodiafiltrationCritical Care, 2010
- A safe citrate anticoagulation protocol with variable treatment efficacy and excellent control of the acid–base status*Critical Care Medicine, 2009
- Citrate anticoagulation for continuous venovenous hemofiltration*Critical Care Medicine, 2009
- Intensity of Renal Support in Critically Ill Patients with Acute Kidney InjuryNew England Journal of Medicine, 2008
- A Practical Citrate Anticoagulation Continuous Venovenous Hemodiafiltration Protocol for Metabolic Control and High Solute ClearanceClinical Journal of the American Society of Nephrology, 2006
- Continuous Venovenous Hemofiltration With Citrate-Based Replacement Fluid: Efficacy, Safety, and Impact on NutritionAmerican Journal of Kidney Diseases, 2005
- Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleedingKidney International, 1999
- Regional hemodialysis anticoagulation: hypertonic tri-sodium citrate or anticoagulant citrate dextrose-AAmerican Journal of Kidney Diseases, 1996
- Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patientsKidney International, 1990